Back to discover
Drug

Nickel

Research stage
Emerging research
RxNorm1311629UNII7OV03QG267
2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

The evolutionary genomics of adaptation to stress in wild rhizobium bacteria.

Research2024-03-20Proceedings of the National Academy of Sciences of the United States of America

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Nickel
RxNorm CUI
1311629
UNII
7OV03QG267

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20222024
Most influential

The evolutionary genomics of adaptation to stress in wild rhizobium bacteria.

Proceedings of the National Academy of Sciences of the United States of America · 2024 · 15 cites
Recent papers

The evolutionary genomics of adaptation to stress in wild rhizobium bacteria.

Proceedings of the National Academy of Sciences of the United States of America · 2024 · 15 cites
Major research themes4
Electrons1Metals, Heavy1Rhizobium1Transition Elements1
Journals, researchers & institutions
Top journals
  • Chemical reviews1
  • Proceedings of the National Academy of Sciences of the United States of America1
Leading researchers
  • Bissonnette NB1
  • Buksh BF1
  • Chan AY1
  • Dexheimer C1
  • Edwards GA1
  • Friesen ML1
  • Frye LI1
  • Garry OL1
Leading institutions
free-text, unnormalised
  • Brigham Young University1
  • Merck Center for Catalysis at Princeton University1
  • School of Biological Sciences1
  • St. Mary's College of Maryland1
  • Washington State University1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature